BRAINBox Solutions

 Company Summary:
  • BRAINBox Solutions, a spinout from ImmunArray USA, is developing a series of products and multiplex tests to assist in the diagnosis and prognosis of Traumatic Brain Injury (“TBI”)
  • Builds on a completed 550 patient longitudinal study done over a two year period and the broadest portfolio of biomarkers in the field
Transaction Overview:
  • Series A financing led by BioVentures
Significance of the Transaction:
  • Provide physicians with objective information to identify and assess severity of suspected TBI from an acute event, monitoring and "return to play" tests will be used during treatment plans
Healthios Role:
  • Healthios served as exclusive financial adviser to BRAINBox Solutions
  • This transaction highlights Healthios commitment to capital formation in emerging growth companies and our success in completing complex transaction to maximize shareholder interests